Phase Ib Trial of Trastuzumab Emtansine In Combination With Lapatinib Plus Abraxane In Metastatic Her 2 Neu Over-Expressed Breast Cancer Patients
Phase of Trial: Phase I/II
Latest Information Update: 25 Oct 2016
At a glance
- Drugs Trastuzumab emtansine (Primary) ; Lapatinib; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms STELA
- 07 Jun 2017 Biomarkers information updated
- 22 Sep 2015 Study phase expanded from phase Ib to phase I/II, planned patient number changed from 18 to 45, as reported by ClinicalTrials.gov.
- 22 Sep 2015 Planned number of patients changed from 18 to 45, as reported by ClinicalTrials.gov.